NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 13 min ago
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)
Funding Opportunity PAR-20-180 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that seek to support the identification of shared mechanisms and development of innovative interventions to address multimorbidity (or multiple chronic conditions (MCCs)) and its consequences. Intervention research supported by this initiative should be designed to study: (1) mechanisms or pathways that prevent MCCs, including the identification of early biomarkers, behavioral pathways, and individual and contextual risk factors and interactions that contribute to the development of common MCCs; (2) targeted therapies and management, including self-management, of MCCs to delay progression and prevent onset of new diseases; and (3) innovative health care partnership models for managing or treating MCCs. Studies may include shared mechanisms, and assessments of interactions between risk factors and interventions that address MCCs at different periods of the lifespan in diverse populations. Use of innovative technologies to assess and intervene on risk factors and pathways are encouraged. Studies may also include those that make use of existing data and/or data linkages to explore new research questions that may be helpful in understanding the impact of mechanisms in isolation or in combination. Of particular interest are interventions that target prevention and treatment of multiple chronic health conditions, including study designs that address therapeutic targets for preventing co-occurring multiple chronic conditions. Prospective applicants whose research interests relate to developing improved measures and methods for understanding multimorbidity, including but not limited to measures/tools to support basic mechanistic discovery of shared MCC pathways and identification and initial evaluation of MCC shared signatures, should see PAR-XX-XXX.
Categories: Job Watch, Literature Watch
U.S. - India Collaborative Environmental Health Research Program (R01 Clinical Trial Optional)
Funding Opportunity RFA-ES-20-010 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to promote collaborative research among US and Indian scientists in the field of environmental health research with a focus on air pollution.
Categories: Job Watch, Literature Watch
Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)
Funding Opportunity PA-20-072 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) hereby notifies grantees holding active AHRQ awards that were funded under the PCOR FOAs, (see referenced FOAs under: Part 1. Overview Information, Activity Code), that funds are available for competitive revisions to meet immediate needs to help address timely health system and healthcare professional response to the COVID-19 public health crisis. This FOA does not include grants that were awarded using AHRQ Health Service Research (HSR) dollars (please see FOA number PA-20-070, which is directed toward those grants). It is expected that competitive revision supplement requests will capitalize on the expertise of grant personnel and the institutional environment to expand the specific aims of the on-going research to develop high-impact new knowledge concerning COVID-19. The proposed projects must support dissemination of comparative clinical effectiveness research findings or the training of researchers in the methods used to conduct such research. Funding will be available in Fiscal Year 2020.
Categories: Job Watch, Literature Watch
Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)
Funding Opportunity PA-20-070 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) hereby notifies grantees holding active AHRQ awards, (except R13s, T32s, F32s), that funds are available for competitive revisions to meet immediate needs to help address timely health system and healthcare professional response to the COVID-19 public health crisis. This FOA does not include grants that were previously funded under FOAs supported by Patient Centered Outcome Research Trust Fund (PCOR TF) dollars (Please see FOA number PA-20-072, which is directed towards those grants).
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Heart, lung, blood and sleep focused ancillary studies to large ongoing clinical trials
Notice NOT-HL-20-755 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Expiration Date for PAR-17-465 "Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)"
Notice NOT-TR-20-025 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of Expiration Date for PAR-18-542 "CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U01 Clinical Trial Optional)"
Notice NOT-NS-20-055 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Key Dates for RFA-NS-20-029 "BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)"
Notice NOT-NS-20-063 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to the Receipt Date of PAR-17-496 and PAR-17-464, "Intervention Research to Improve Native American Health (R01/R21 Clinical Trial Optional)"
Notice NOT-CA-20-053 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to the First Receipt Date of RFA-CA-20-027 and RFA-CA-20-028, "Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01/R21 Clinical Trial Optional)"
Notice NOT-CA-20-057 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification to Eligibility Information in RFA- AI-20-029 Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional)
Notice NOT-AI-20-045 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change in Key Dates for RFA-AI-20-008 , Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional)
Notice NOT-AI-20-046 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Expiration Date for PAR-17-170 "Alcohol Research Resource Awards (R24)"
Notice NOT-AA-20-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of Expiration Date for PAR-17-456 "CREATE Bio Optimization Track for Biologics (U01 Clinical Trial Not Allowed)"
Notice NOT-NS-20-053 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK"
Notice NOT-DK-20-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of Expiration Date for PAR-17-457 "CREATE Bio Optimization Track for Biologics (SBIR) (U44 Clinical Trial Not Allowed)"
Notice NOT-NS-20-054 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information: Soliciting Input for the National Center for Complementary and Integrative Healths New Strategic Plan
Notice NOT-AT-20-013 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Expiration Date for PAR-18-462 "Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed)"
Notice NOT-TR-20-027 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Application Due Date for RFA-CA-19-045 "Participant Engagement and Cancer Genome Sequencing (PE-CGS) (U2C Clinical Trial Optional)"
Notice NOT-CA-20-056 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Expiration Date for PAR-18-332 "Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)"
Notice NOT-TR-20-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch